Ola Electric Mobility shares fall 7%, back below IPO price, after three-month lock-in ends

Ola Electric, in an exchange filing on Monday, highlighted that it will hold a board meet on November 8 to disclose its September quarter results.

Ola Electric, in an exchange filing on Monday, highlighted that it will hold a board meet on November 8 to disclose its September quarter results.

Morgan Stanley’s Asia CEO and Co-Head of Global Equities, Gokul Laroia attributes the recent decline in Indian equities to short-term portfolio adjustments by investors.

Order inflows during the quarter for ABB India stood at ₹3,342 crore, which is a growth of 11% from last year, but the number was lower than the IIFL estimate of ₹3,510 crore.

Angel One Share Price | The company reported gross client additions of 7 lakh in October, down by 26.32% from 9.5 lakh in September. This reversal follows a 5.5% uptick in new client registrations seen in September, which may have…

Matt Orton, Chief Market Strategist at Raymond James Investment said that regardless of the US election outcome, specific emerging markets, including India, still present strong investment opportunities.

Shares of Tilaknagar Industries have given positive annual returns every single calendar year since 2020, having risen 123% that year, 213% in 2021, 18% in 2022 and another 118% in 2023.

NBCC Share Price | As per the order, NBCC will construct buildings at BIS headquarters in New Delhi, central laboratory, Sahibabad, National Institute of Training for standardisation, Noida, Northern Regional Laboratory, Mohali and Bangalore Branch Laboratory, Bengaluru.

Analysts have given mixed ratings on the Swiggy IPO. While some advise investors to subscribe, citing a fair valuation, others recommend avoiding it due to “reported negative” cash flows, ongoing losses, and challenges in the growth strategy.

Solar Industries shares have corrected 27% from its record high of ₹13,298, but is still holding to gains of 40% on a year-to-date basis.

Under the new CEO, Kotak said it would monitor the progress of Gland Pharma’s proposed B2C strategy in regulated markets, especially given the CEO’s limited experience in these pharma markets, which contribute 75% of Gland’s total sales. Additionally, Kotak will…